TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7% January 28, 1977
TCL Archive Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle September 30, 1994